# Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect

> **NCT00807118** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 108 (estimated)

## Conditions studied

- Therapeutic Equivalency
- Food

## Interventions

- **DRUG:** Fesoterodine
- **DRUG:** Fesoterodine
- **DRUG:** Fesoterodine
- **DRUG:** Fesoterodine
- **DRUG:** Fesoterodine
- **DRUG:** Fesoterodine

## Key facts

- **NCT ID:** NCT00807118
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2010-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00807118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00807118, "Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00807118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*